N/A
Manufactured by Viatris Specialty LLC
33,596 FDA adverse event reports analyzed
Last updated: 2026-04-14
TOLTERODINE TARTRATE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Viatris Specialty LLC. The most commonly reported adverse reactions for TOLTERODINE TARTRATE include DRUG INEFFECTIVE, FALL, FATIGUE, NAUSEA, DIZZINESS. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TOLTERODINE TARTRATE.
Out of 16,134 classified reports for TOLTERODINE TARTRATE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 33,596 FDA FAERS reports that mention TOLTERODINE TARTRATE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG INEFFECTIVE, FALL, FATIGUE, NAUSEA, DIZZINESS, HEADACHE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Viatris Specialty LLC in connection with TOLTERODINE TARTRATE. Always verify the specific product and NDC with your pharmacist.